Rabeprazole 20mg + Itopride 150mg capsule is a combination gastrointestinal formulation developed for the management of acid-related disorders accompanied by impaired gastric motility, offering balanced symptom control and improved digestive comfort.
Rabeprazole works by inhibiting gastric acid secretion at the proton pump, while itopride enhances gastrointestinal motility by improving gastric emptying and reducing reflux episodes, helping relieve acidity, heartburn, bloating, nausea, and post-meal discomfort.
This capsule is commonly prescribed for gastroesophageal reflux disease (GERD), functional dyspepsia, chronic gastritis, acid peptic disorders, and conditions involving delayed gastric emptying.
With dual-action efficacy, strong prescription acceptance, and suitability for long-term digestive care, this formulation supports consistent therapeutic demand and strengthens a comprehensive gastrointestinal product portfolio.